The concordant findings showed an increase in GDF15 expression in irradiated oral cancer cells [41], an increase in plasma GDF15 levels in chemotherapeutic-resistant testicular cancer patients [42], and increased sensitivity to chemo-drug treatment after GDF15 knockdown in a mouse model of ovarian cancer [43]. The gene discussed is GDF15; the disease is ovarian cancer.